e-learning
resources
Munich 2014
Monday, 08.09.2014
COPD physiopathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelial dysfunction and systemic inflammation in different COPD phenotypes
A. Vukic Dugac, M. Jakopovic, S. Popovic-Grle, B. Barisic, S. Badovinac, M. Samarzija, A. Ruzic (Zagreb, Rijeka, Croatia)
Source:
International Congress 2014 – COPD physiopathology
Session:
COPD physiopathology
Session type:
Oral Presentation
Number:
2951
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Vukic Dugac, M. Jakopovic, S. Popovic-Grle, B. Barisic, S. Badovinac, M. Samarzija, A. Ruzic (Zagreb, Rijeka, Croatia). Endothelial dysfunction and systemic inflammation in different COPD phenotypes. Eur Respir J 2014; 44: Suppl. 58, 2951
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
COPD: Left ventricular dysfunction, systemic inflammation and endothelial dysfunction
Source: International Congress 2014 – Markers
Year: 2014
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Role of activated complement in COPD exacerbation recovery
Source: International Congress 2014 – Comorbidities
Year: 2014
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept